Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The parathyroid hormone/parathyroid hormone-related peptide receptor type 1 (PTH1R) is a Class B GPCR that serves as the primary receptor for both parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP). It plays a critical role in regulating skeletal development, bone turnover, and mineral ion homeostasis, particularly calcium and phosphate balance. PTH1R is highly expressed in bone, kidney, and cartilage. Ligand binding activates G proteins, stimulating adenylyl cyclase and increasing intracellular cAMP, or activating the phospholipase C pathway and mobilizing intracellular calcium. Mutations in PTH1R are associated with several skeletal disorders, and it is a therapeutic target for conditions like osteoporosis and hypoparathyroidism.
Agonists stimulate adenylyl cyclase/cAMP pathway or phospholipase C/Ca2+ pathway to regulate bone metabolism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Parathyroid hormone/Parathyroid hormone-related peptide receptor type 1 (PTH1R).